What Happened?
Seattle, WA-based Good-Therapeutics Appointed John Mulligan as Founder and Chief Executive Officer
About the Company
Good Therapeutics is an early-stage biotechnology company based in Seattle, Washington. We are developing "context-dependent" protein drugs that sense biomarkers and respond with a therapeutic activity. Our goal is to make safer, more effective drugs that act only when and where they are needed, limiting systemic toxicity without reducing therapeutic efficacy.
About the Person
John Mulligan is Founder and Chief Executive Officer at Good Therapeutics. Previously, John held various senior HR leadership roles in the industry.
Info Source
News
Short Profile